GRAIL (GRAL) FCF Margin %: -214.52% (As of Mar. 2026)


GRAL GRAIL Inc GRAL
12 GF Score
Price $66.28
! 2 Warning Signs
View Full Analysis

What is GRAIL FCF Margin %?

GRAIL GRAL -0.44% 12 FCF Margin % is -214.52% as of Mar. 2026. GuruFocus rates GRAL with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, GRAIL ranks worse than 84.31% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. GRAIL's Free Cash Flow for the three months ended in Mar. 2026 was $-87.5 Mil. GRAIL's Revenue for the three months ended in Mar. 2026 was $40.8 Mil. Therefore, GRAIL's FCF Margin % for the quarter that ended in Mar. 2026 was -214.52%.

As of today, GRAIL's current FCF Yield % is -10.28%.

The historical rank and industry rank for GRAIL's FCF Margin % or its related term are showing as below:

GRAL' s FCF Margin % Range Over the Past 10 Years
Min: -1051.61   Med: -558.72   Max: -187.25
Current: -187.25

During the past 6 years, the highest FCF Margin % of GRAIL was -187.25%. The lowest was -1051.61%. And the median was -558.72%.

GRAL's FCF Margin % is ranked worse than
84.31% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845 vs GRAL: -187.25

GRAIL FCF Margin % Related Terms

GRAIL FCF Margin % Historical Data

* Premium members only.

The historical data trend for GRAIL's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GRAIL FCF Margin % Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 -1,051.61 -653.76 -463.68 -203.79

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -298.63 -217.57 -175.80 -146.52 -214.52

GRAL vs VCYT, ADPT, TWST: FCF Margin % Comparison

For the Diagnostics & Research subindustry, GRAIL's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GRAIL FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GRAIL's FCF Margin % distribution charts can be found below:

* The bar in red indicates where GRAIL's FCF Margin % falls into.


GRAL
12GF Score
GRAIL Inc GRAL
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GRAIL FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

GRAIL's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-299.916/147.172
=-203.79 %

GRAIL's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-87.492/40.785
=-214.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -214.52% mean?
GRAIL (GRAL) has a FCF Margin % of -214.52% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on GRAIL and its competitors. According to the industry distribution chart, GRAIL ranks #172 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 84.3%.
Is GRAIL's FCF Margin % too high?
GRAIL's current FCF Margin % is -214.52%. Based on the distribution chart, GRAIL ranks #172 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, GRAIL has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does GRAIL's FCF Margin % compare to VCYT and ADPT?
According to the Medical Diagnostics & Research industry distribution chart, GRAIL ranks #172 out of 204 companies for FCF Margin %. This places GRAIL in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on GRAIL and its competitors. GRAIL's current FCF Margin % is -214.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GRAIL stock overvalued right now?
GRAIL (GRAL) has a current FCF Margin % of -214.52%. The current FCF Margin % is -214.52%. GRAIL's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For GRAIL (GRAL), the current FCF Margin % is -214.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GRAIL Business Description

Other Exchanges NL0:Germany
Address 1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
12GF Score

Get the complete analysis for GRAL

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$66.28
Price